Perspective Therapeutics, Inc.
CATX · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,969 | $6,475 | -$18,177 | -$40,169 |
| Dep. & Amort. | $775 | $1,183 | $732 | $721 |
| Deferred Tax | $0 | -$7,849 | $0 | -$2,097 |
| Stock-Based Comp. | $2,156 | $4,501 | $2,098 | $2,060 |
| Change in WC | $7,290 | -$913 | -$5,383 | -$11,437 |
| Other Non-Cash | -$544 | -$23,350 | -$852 | $24,316 |
| Operating Cash Flow | -$16,292 | -$13,831 | -$21,582 | -$26,606 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,992 | -$4,811 | -$4,656 | -$14,614 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$32,131 | -$67,094 | -$22,604 | -$164,780 |
| Inv. Sales/Matur. | $48,154 | $71,520 | $21,704 | $40,505 |
| Other Inv. Act. | -$39 | $4,649 | -$9 | $287 |
| Investing Cash Flow | $13,992 | $4,264 | -$5,565 | -$138,602 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$13 | -$13 | -$13 | -$12 |
| Stock Issued | $226 | $145 | $9,986 | -$13,144 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $12,248 |
| Financing Cash Flow | $213 | $132 | $9,973 | $345 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,087 | -$15,557 | -$17,174 | -$164,863 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28,849 | $44,406 | $61,580 | $226,443 |
| End Cash | $26,762 | $28,849 | $44,406 | $61,580 |
| Free Cash Flow | -$18,284 | -$18,642 | -$26,238 | -$41,220 |